Accessibility Menu
N2off logo

N2off(NASDAQ) SVFD

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)-100%
5 Year-100%
1 Year-97%
1 Month+5%
N/A
N2off last closing stock price
MetricPriceDate
Last closeUSD 1.802026-08-31
N2off stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.12%USD 1.782026-08-24
1 month+5.26%USD 1.712026-07-31
3 month-67.57%USD 5.552026-06-02
Year to date-84.69%USD 11.762025-12-31
1 year-96.67%USD 54.002025-08-29
3 year-99.82%USD 974.122023-09-01
5 year-99.99%USD 13,776.602021-09-01
Since inception-99.99%USD 36,015.272010-11-12

N2off Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$4.01B

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Mar 25, 2024

SVFD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About N2off

Nexentis Technologies Inc. is a biotechnology company focused on developing therapeutics for cancer and inflammatory metabolic diseases. The company operates through two segments: Biotechnology Activity and Renewable Energy Projects, showcasing a diverse approach to innovation in healthcare.

Products and Services
  • MITOLINE algorithm for mitochondrial carrier protein modeling
  • Cloud-based computational chemistry platform for drug discovery
  • Advanced 3D NSCLC tumor spheroid systems for research
Growth Outlook
  • Recent quarterly net income loss of $11.1 million indicates ongoing investment in R&D
  • Cash and short-term investments increased to $8.9 million, supporting future projects
  • Operating cash flow ratio of 68.6% suggests efficient cash management despite losses
Financial Highlights
  • Trailing twelve months (TTM) revenue of $0, reflecting early-stage development
  • Operating income margin of -177.5% highlights significant investment in growth
  • Current ratio of 3.72 indicates strong liquidity position for operational needs
Nexentis Technologies Inc. is positioned in the biotechnology sector, focusing on innovative solutions for complex health challenges. The company's diverse product offerings, including advanced computational tools and in-vitro screening platforms, aim to enhance drug discovery and development processes. Despite recent financial challenges, including a significant net income loss, the increase in cash reserves and a strong current ratio suggest a solid foundation for future growth. The ongoing investment in research and development reflects a commitment to advancing its therapeutic pipeline, which may attract interest from investors looking for opportunities in the biotechnology field.
AI Generated • Aug 21, 2026

Industry

Chemicals

Sector

Materials

Employees

5

CEO

David Palach, CPA

Website

www.n2off.com

Headquarters

Miami, FL 33172, US

SVFD Financials

Key Financial Metrics (TTM)

Gross Margin

351.52%

Operating Margin

5781.82%

Net Income Margin

8730.30%

Return on Equity

-45.94%

Return on Capital

-21452.44%

Return on Assets

-43.64%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$50.00K

Operating Income

-$3.60B

EBITDA

$207.00K

Operating Cash Flow

-$4.43M

Capital Expenditure

$0.00

Free Cash Flow

-$4.43M

Cash & ST Invst.

$8.88M

Total Debt

$219.00K

N2off Performance Analysis

N2off annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 394,004-10.1%
20232023-12-31USD 263,445-33.1%
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
N2off sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
N2off annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -2,813.80136664.9%
20232023-12-31USD -1,330.98-52.7%
20242024-12-31USD -194.16-85.4%
20252025-12-31USD -25.02-87.1%
N2off sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30416.7%
Q42025-12-31-1680.7%
Q12026-03-31-19.2%
Q22026-06-30100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

6

N/A

Net Income

$0.00

+100.0%

EBITDA

$0.00

-100.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$8.88M

+160.5%

Total Debt

$219.00K

+1584.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$219.00K

N/A

Return on Assets

-43.64%

N/A

Return on Invested Capital

-29.46%

N/A

Free Cash Flow

-$539.00K

-2.1%

Operating Cash Flow

-$539.00K

-2.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HYMCHycroft Mining Holding Corporation
$23.43-1.66%
BYUBAIYU Holdings, Inc.
$0.18-1.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
WETOWetour Robotics
$5.48-0.04%
IBITiShares Bitcoin Trust
$44.67+0.02%
INTCIntel
$89.51+0.00%

Questions About SVFD

What is the current price of N2off?

N2off is trading at N/A per share.

What is the 52-week range for N2off?

Over the past 52 weeks, N2off has traded between N/A and N/A.

How much debt does N2off have?

As of the most recent reporting period, N2off reported total debt of $426.00K.

How much cash does N2off have on hand?

N2off reported $7.66M in cash and cash equivalents in its most recent financial results.

What is N2off’s dividend yield?

N2off does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services